Experimental stroke drug NCS-01 enters human safety trials
NCT ID NCT03915431
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-phase trial tests whether a new drug called NCS-01 is safe for people who have had a stroke. Sixteen patients will receive the drug within 48 hours of their stroke. The main goal is to check for side effects, not to see if the drug works. This is a first step to see if larger studies are possible.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NCS-01
What this could lead to
If safe, this could pave the way for a new treatment to reduce brain damage after a stroke.
What could go wrong
This is a very early, small study (16 people) focused only on safety. It is not designed to prove the drug works, and many early-stage treatments fail to show benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Miami
Miami, Florida, 33136, United States